Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
56.93
-0.31 (-0.54%)
At close: May 1, 2026, 4:00 PM EDT
52.69
-4.24 (-7.45%)
After-hours: May 1, 2026, 7:11 PM EDT
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $8.22 billion as of May 1, 2026. Its market cap has increased by 119.23% in one year.
Market Cap
8.22B
Enterprise Value
6.78B
1-Year Change
119.23%
Ranking
Category
Stock Price
$56.93
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $8.22B, an increase of 495.67%. That is a compound annual growth rate of 35.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 8.22B | 36.09% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioMarin Pharmaceutical | 10.42B |
| Arrowhead Pharmaceuticals | 10.29B |
| ABIVAX Société Anonyme | 8.96B |
| Praxis Precision Medicines | 8.88B |
| Bio-Techne | 8.65B |
| Cytokinetics | 7.95B |
| Nuvalent | 7.88B |
| Krystal Biotech | 7.72B |